Laura and ISAAC Perlmutter Cancer Center at NYU Langone. — New York, New York

Laura and ISAAC Perlmutter Cancer Center at NYU Langone. is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Laura and ISAAC Perlmutter Cancer Center at NYU Langone. has participated in 12 clinical trials with 2 currently active.

Therapeutic areas: Renal Cell Carcinoma, Carcinoma, Hepatocellular, Neoplasm Metastasis.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and ISAAC Perlmutter Cancer Center at NYU Langone.?

Laura and ISAAC Perlmutter Cancer Center at NYU Langone. has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and ISAAC Perlmutter Cancer Center at NYU Langone. conducted?

Laura and ISAAC Perlmutter Cancer Center at NYU Langone. has 12 clinical trials on record, with 2 currently active. Their work covers Renal Cell Carcinoma, Carcinoma, Hepatocellular, Neoplasm Metastasis.

Is Laura and ISAAC Perlmutter Cancer Center at NYU Langone. accredited by Crixeo Health?

Yes — Laura and ISAAC Perlmutter Cancer Center at NYU Langone. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laura and ISAAC Perlmutter Cancer Center at NYU Langone.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.